Table 1.
Group | Days in Treatment | Control | 20 ppm | 50 ppm | 100 ppm |
---|---|---|---|---|---|
BW_initial (g) | 5 | 326.7 ± 15.2 | 323.6 ± 10.7 | 324.0 ± 9.60 | 331.1 ± 9.93 |
10 | 325.5 ± 13.9 | 329.4 ± 6.9 | 336.9 ± 15.6 | 329.8 ± 20.6 | |
BW_final (g) | 5 | 346.7 ± 14.6 b | 316.9 ± 17.5 a | 315.5 ± 17.2 a | 308.1 ± 15.1 a |
10 | 368.0 ± 11.6 b | 321.8 ± 28.5 ab | 283.4 ± 36.1 a | 270.7 ± 47.9 a | |
BW_gain (g) | 5 | 19.9 ± 2.29 c | -6.73 ± 7.97 b | −8.55 ± 7.95 b | −23 ± 10.7 a |
10 | 42.5 ± 13.4 c | -7.58 ± 30.0 b | −53.5 ± 29.0 ab | −59.1 ± 34.1 a | |
liver (g) | 5 | 14.1 ± 1.18 b | 10.1 ± 1.37 a | 10.1 ± 0.87 a | 8.97 ± 0.41 a |
10 | 15.2 ± 1.14 b | 9.12 ± 2.55 a | 7.83 ± 1.66 a | 7.45 ± 1.41 a | |
rel. liver (%) | 5 | 4.07 ± 0.28 b | 3.15 ± 0.29 a | 3.22 ± 0.21 a | 2.92 ± 0.08 a |
10 | 4.12 ± 0.22 b | 2.92 ± 0.52 a | 2.73 ± 0.32 a | 2.80 ± 0.19 a | |
kidney (g) | 5 | 2.33 ± 0.19 | 2.07 ± 0.12 | 2.27 ± 0.27 | 2.07 ± 0.16 |
10 | 2.47 ± 0.21 ab | 2.42 ± 0.22 ab | 2.30 ± 0.22 a | 2.77 ± 0.39 b | |
rel. kidney (%) | 5 | 0.68 ± 0.04 | 0.63 ± 0.05 | 0.72 ± 0.10 | 0.67 ± 0.08 |
10 | 0.67 ± 0.05 a | 0.78 ± 0.15 a | 0.83 ± 0.10 ab | 1.05 ± 0.21 b | |
lung (g) | 5 | 2.35 ± 0.28 b | 1.82 ± 0.40 a | 1.60 ± 0.22 a | 1.52 ± 0.12 a |
10 | 1.73 ± 0.14 | 1.60 ± 0.13 | 1.55 ± 0.14 | 1.58 ± 0.13 | |
rel. lung. % | 5 | 0.68 ±0.07 b | 0.57 ± 0.13 ab | 0.51 ± 0.07 a | 0.49 ± 0.04 a |
10 | 0.47 ± 0.04 a | 0.52 ± 0.04 ab | 0.55 ± 0.06 ab | 0.60 ± 0.07 b |
a, b: small uppercase letters indicate significant difference (p < 0.05) between means of one row. Bold number pairs indicate significant difference (p < 0.05) between 5 and 10-day treatment data.